GSK accelerates data analytics for clinical trials

GlaxoSmithKline is dreaming big with its big data. By tapping decades’ worth of clinical trial data, the pharmaceutical giant aims to deliver drugs to market more quickly. If it succeeds, it could seize an advantage in an industry oft-maligned for its plodding pace.To read this article in full or to leave a comment, please click here(Insider Story)